Prevalence of metabolic disturbances among women with polycystic ovary syndrome in different regions of Brazil

被引:12
作者
Maffazioli, Giovana D. N. [1 ]
Lopes, Caroline P. [1 ]
Heinrich-Oliveira, Vanessa [1 ]
Lobo, Rogerio A. [2 ]
Hayashida, Sylvia A. Y. [1 ]
Soares, Jose Maria, Jr. [1 ]
Maciel, Gustavo A. R. [1 ]
Baracat, Edmund C. [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Disciplina Ginecol,Dept Obstet & Ginecolo, Sao Paulo, Brazil
[2] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA
基金
巴西圣保罗研究基金会;
关键词
Diabetes; Dyslipidemia; Hyperinsulinemia; Metabolic syndrome; Metabolism; Polycystic ovary syndrome; INSULIN-RESISTANCE; DIFFERENT PHENOTYPES; CARDIOVASCULAR RISK; ROTTERDAM CRITERIA; GENOMIC ANCESTRY; SYNDROME PCOS; ASSOCIATION; GLUCOSE; OBESITY; HYPERANDROGENISM;
D O I
10.1002/ijgo.13374
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To describe the prevalence of metabolic disturbances in a large cohort of women with polycystic ovary syndrome (PCOS) in southeastern Brazil and to compare the findings with other cohorts of Brazilian women with PCOS. Methods A retrospective study analyzing clinical and laboratory data of 462 women with PCOS treated at an outpatient clinic in a tertiary hospital in southeastern Brazil. Prevalence of insulin resistance, glucose intolerance, type 2 diabetes, dyslipidemia, central obesity, hypertension, and metabolic syndrome was compared to that of other cohorts of age and body mass index-matched Brazilian women with PCOS. Results Women with PCOS had a median age of 25.0 (21.0-29.0) years and BMI of 28.7 (23.9-34.0) kg/m(2). Prevalence of insulin resistance, glucose intolerance, and type 2 diabetes varied from 39.6% to 55.0%, 7.2% to 28.1%, and 2.0% to 4.1%, respectively. Prevalence of central obesity, dyslipidemia due to decreased high-density lipoprotein cholesterol, hypertriglyceridemia, and metabolic syndrome ranged from 57.8% to 66.4%, 54.1% to 70.4%, 22.9% to 35.1%, and 27.4% to 38.3%, respectively, which did not differ among regions in Brazil. Conclusion Prevalence of metabolic disturbances was high among Brazilian women with PCOS. This study suggests that, from a public health perspective, authorities in Brazil should be aware of and encourage screening for metabolic dysfunction in women with PCOS in all regions of the country.
引用
收藏
页码:383 / 391
页数:9
相关论文
共 50 条
  • [31] The metabolic syndrome in polycystic ovary syndrome
    Essah, PA
    Nestler, JE
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2006, 29 (03) : 270 - 280
  • [32] Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
    Gabrielli, Ligia
    Aquino, Estela M. L.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2012, 10
  • [33] Metabolic Features of Women With Polycystic Ovary Syndrome in Latin America: A Systematic Review
    Marchesan, Lucas Bandeira
    Ramos, Ramon Bossardi
    Spritzer, Poli Mara
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [34] Prevalence and factors associated with non-alcoholic fatty liver disease among women with polycystic ovary syndrome
    Franciscatto, Maria Elisa
    Taniguchi, Juliana Bosso
    Wohlenberg, Raquel
    Riedi, Isadora Luisa
    Oppermann, Karen
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2024, 46
  • [35] Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances
    Spritzer, Poli Mara
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2014, 58 (02) : 182 - 187
  • [36] Systemic and ovarian inflammation in women with polycystic ovary syndrome
    Zhai, Yi
    Pang, Yanli
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2022, 151
  • [37] Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
    Al-Jefout, Moamar
    Alnawaiseh, Nedal
    Al-Qtaitat, Aiman
    SCIENTIFIC REPORTS, 2017, 7
  • [38] Criteria, phenotypes and prevalence of polycystic ovary syndrome
    Belenkaia, Liliia, V
    Lazareva, Lyudmila M.
    Walker, Walidah
    Lizneva, Dana, V
    Suturina, Larisa, V
    MINERVA GINECOLOGICA, 2019, 71 (03): : 211 - 223
  • [39] Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset
    Espinos-Gomez, Juan J.
    Rodriguez-Espinosa, J.
    Ordonez-Llanos, J.
    Calaf-Alsina, J.
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (04) : 264 - 268
  • [40] Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome
    Mafaldo Soares, Elvira Maria
    Azevedo, George Dantas
    Nobrega Gadelha, Rafael Goncalves
    Araujo Moura Lemos, Telma Maria
    Oliveira Maranhao, Tecia Maria
    FERTILITY AND STERILITY, 2008, 89 (03) : 649 - 655